Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.
2.

The effects of fluoxetine and buspirone on self-injurious and stereotypic behavior in adult male rhesus macaques.

Fontenot MB, Padgett EE 3rd, Dupuy AM, Lynch CR, De Petrillo PB, Higley JD.

Comp Med. 2005 Feb;55(1):67-74.

PMID:
15766212
3.

Effects of outdoor housing on self-injurious and stereotypic behavior in adult male rhesus macaques (Macaca mulatta).

Fontenot MB, Wilkes MN, Lynch CS.

J Am Assoc Lab Anim Sci. 2006 Sep;45(5):35-43.

PMID:
16995645
4.

Self-injurious behavior is decreased by cyproterone acetate in adult male rhesus (Macaca mulatta).

Eaton GG, Worlein JM, Kelley ST, Vijayaraghavan S, Hess DL, Axthelm MK, Bethea CL.

Horm Behav. 1999 Apr;35(2):195-203.

PMID:
10202127
5.

Effect of tryptophan treatment on self-biting and central nervous system serotonin metabolism in rhesus monkeys (Macaca mulatta).

Weld KP, Mench JA, Woodward RA, Bolesta MS, Suomi SJ, Higley JD.

Neuropsychopharmacology. 1998 Oct;19(4):314-21.

6.

Pharmacokinetics of fluoxetine in rhesus macaques following multiple routes of administration.

Sawyer EK, Howell LL.

Pharmacology. 2011;88(1-2):44-9. doi: 10.1159/000329417. Epub 2011 Jul 14.

7.

Effect of halving the dose of venlafaxine to adjust for putative pharmacokinetic and pharmacodynamic changes in an animal model of chronic hepatic encephalopathy.

Wikell C, Kugelberg FC, Hjorth S, Apelqvist G, Bengtsson F.

Clin Neuropharmacol. 2001 Nov-Dec;24(6):324-33.

PMID:
11801807
8.

Omega-3 fatty acid deficiency does not alter the effects of chronic fluoxetine treatment on central serotonin turnover or behavior in the forced swim test in female rats.

McNamara RK, Able JA, Liu Y, Jandacek R, Rider T, Tso P, Lipton JW.

Pharmacol Biochem Behav. 2013 Dec;114-115:1-8. doi: 10.1016/j.pbb.2013.09.010. Epub 2013 Oct 1.

9.

Use of guanfacine to control self-injurious behavior in two rhesus macaques (Macaca mulatta) and one baboon (Papio anubis).

Macy JD Jr, Beattie TA, Morgenstern SE, Arnsten AF.

Comp Med. 2000 Aug;50(4):419-25.

PMID:
11020162
10.

Venlafaxine metabolism as a marker of cytochrome P450 enzyme 2D6 metabolizer status.

Nichols AI, Lobello K, Guico-Pabia CJ, Paul J, Preskorn SH.

J Clin Psychopharmacol. 2009 Aug;29(4):383-6. doi: 10.1097/JCP.0b013e3181acc4dd.

PMID:
19593180
11.

Fluoxetine: juvenile pharmacokinetics in a nonhuman primate model.

Golub MS, Hogrefe CE.

Psychopharmacology (Berl). 2014 Oct;231(20):4041-7. doi: 10.1007/s00213-014-3537-y. Epub 2014 Apr 4.

12.

Combining bupropion SR with venlafaxine, paroxetine, or fluoxetine: a preliminary report on pharmacokinetic, therapeutic, and sexual dysfunction effects.

Kennedy SH, McCann SM, Masellis M, McIntyre RS, Raskin J, McKay G, Baker GB.

J Clin Psychiatry. 2002 Mar;63(3):181-6.

PMID:
11926715
14.
15.

Brain monoamine output alterations after a single venlafaxine challenge in experimental hepatic encephalopathy.

Wikell C, Bergqvist PB, Hjorth S, Apelqvist G, Björk H, Bengtsson F.

Clin Neuropharmacol. 1998 Sep-Oct;21(5):296-306.

PMID:
9789710
16.

Maternal fluoxetine treatment decreases behavioral response to dopaminergic drugs in female pups.

Favaro Pd, Costa LC, Moreira EG.

Neurotoxicol Teratol. 2008 Nov-Dec;30(6):487-94. doi: 10.1016/j.ntt.2008.05.002. Epub 2008 May 14.

PMID:
18586456
17.

Fluoxetine and norfluoxetine.

Mattes JA.

Am J Psychiatry. 1998 Nov;155(11):1637. No abstract available.

PMID:
9812147
18.

Evidence of the dual mechanisms of action of venlafaxine.

Harvey AT, Rudolph RL, Preskorn SH.

Arch Gen Psychiatry. 2000 May;57(5):503-9.

PMID:
10807491
19.

Long-term effects of early social isolation in Macaca mulatta: changes in dopamine receptor function following apomorphine challenge.

Lewis MH, Gluck JP, Beauchamp AJ, Keresztury MF, Mailman RB.

Brain Res. 1990 Apr 9;513(1):67-73.

PMID:
1693540
20.

The efficacy of diazepam treatment for the management of acute wounding episodes in captive rhesus macaques.

Tiefenbacher S, Fahey MA, Rowlett JK, Meyer JS, Pouliot AL, Jones BM, Novak MA.

Comp Med. 2005 Aug;55(4):387-92.

PMID:
16158915

Supplemental Content

Support Center